Richard Markus has sold RCUS and made no open-market buys since Dec 2025

Richard Markus, M.D., Ph.D., is the Chief Medical Officer at Arcus Biosciences, Inc. (RCUS), a position he has held since January 2025.( In this role, he reports to CEO Terry Rosen and oversees clinical development efforts for the company's cancer therapies.(

Dr. Markus brings over 25 years of experience in biotechnology and pharmaceuticals.( His career highlights include serving as CEO of Dantari, Inc. from February 2019 to August 2024, where he led development of targeted cancer therapeutics; Vice President of Global Development at Amgen from 2006 to 2019, including leadership on denosumab; Senior Medical Director at Corus Pharma (acquired by Gilead); and Medical Director at Allecure (2000-2003).( He earned his MD and PhD in Epidemiology from the University of Southern California Keck School of Medicine in 1997, and a BS in Cybernetics from UCLA.(

Written by Perplexity from public sources.